BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31827061)

  • 1. Transmembrane and Ubiquitin-Like Domain Containing 1 Protein (TMUB1) Negatively Regulates Hepatocellular Carcinoma Proliferation via Regulating Signal Transducer and Activator of Transcription 1 (STAT1).
    Chen Y; Fu H; Zhang Y; Chen P
    Med Sci Monit; 2019 Dec; 25():9471-9482. PubMed ID: 31827061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAPZA1 modulates EMT by regulating actin cytoskeleton remodelling in hepatocellular carcinoma.
    Huang D; Cao L; Zheng S
    J Exp Clin Cancer Res; 2017 Jan; 36(1):13. PubMed ID: 28093067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogene Delta/Notch-Like EGF-Related Receptor Promotes Cell Proliferation, Invasion, and Migration in Hepatocellular Carcinoma and Predicts a Poor Prognosis.
    Liang Y; Luo H; Zhang H; Dong Y; Bao Y
    Cancer Biother Radiopharm; 2018 Nov; 33(9):380-386. PubMed ID: 30235011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
    Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tmub1 Suppresses Hepatocellular Carcinoma by Promoting the Ubiquitination of ΔNp63 Isoforms.
    Fu H; Zhang Y; Chen J; Zhou B; Chen G; Chen P
    Mol Ther Oncolytics; 2020 Sep; 18():126-136. PubMed ID: 32671188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT1 negatively regulates hepatocellular carcinoma cell proliferation.
    Chen G; Wang H; Xie S; Ma J; Wang G
    Oncol Rep; 2013 Jun; 29(6):2303-10. PubMed ID: 23588992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Over-expression of miR-141 inhibits the proliferation, invasion and migration of hepatocellular carcinoma MHCC-97H cells].
    Yao B; Xue Y; Liu Z; Xu M; Tu K; Wang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1083-7. PubMed ID: 27412940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
    World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-486-5p Suppresses Proliferation and Migration of Hepatocellular Carcinoma Cells through Downregulation of the E3 Ubiquitin Ligase CBL.
    He J; Xiao B; Li X; He Y; Li L; Sun Z
    Biomed Res Int; 2019; 2019():2732057. PubMed ID: 31976317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma.
    Zhou J; Li W; Guo J; Li G; Chen F; Zhou J
    Tumour Biol; 2016 Mar; 37(3):3561-9. PubMed ID: 26456956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX18 Affects Cell Viability, Migration, Invasiveness, and Apoptosis in Hepatocellular Carcinoma (HCC) Cells by Participating in Epithelial-to-Mesenchymal Transition (EMT) Progression and Adenosine Monophosphate Activated Protein Kinase (AMPK)/Mammalian Target of Rapamycin (mTOR).
    Sun Y; Lei B; Huang Q
    Med Sci Monit; 2019 Aug; 25():6244-6254. PubMed ID: 31427562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA AIRN influences the proliferation and apoptosis of hepatocellular carcinoma cells by regulating STAT1 ubiquitination.
    Cai H; Zheng Y; Wen Z; Yang Y; Yang S; Zhang Q
    Arch Pharm Res; 2021 Apr; 44(4):414-426. PubMed ID: 33759138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
    Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
    EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of eEF1A1 regulates G1-phase progression to promote HCC proliferation through the STAT1-cyclin D1 pathway.
    Huang J; Zheng C; Shao J; Chen L; Liu X; Shao J
    Biochem Biophys Res Commun; 2017 Dec; 494(3-4):542-549. PubMed ID: 29079187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression.
    Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H
    Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [miR-491 inhibits the proliferation, invasion and migration of hepatocellular carcinoma cell via down-regulating TPX2 expression].
    Wang J; Liu Z; Dou C; Han S; Li C; Tu K; Yang W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Apr; 32(4):512-7. PubMed ID: 27053618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.